UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000014189 |
|---|---|
| Receipt number | R000016319 |
| Scientific Title | Reinduction with lapatinib followed by retreatment with trastuzumab-based therapy after disease progression multi-HER2 targeted therapies in HER2-positive metastatic breast cancer |
| Date of disclosure of the study information | 2014/06/06 |
| Last modified on | 2020/06/07 10:32:03 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/06/06 15:05:05 | ||
| 2 | Update | 2015/12/06 10:00:51 | Name of person sending information Name of person sending information |
|
| 3 | Update | 2015/12/06 10:04:10 | Recruitment status |
|
| 4 | Update | 2020/06/07 10:30:16 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Zip code Name of primary person or sponsor Organization Organization Organization Address Address Tel |
|
| 5 | Update | 2020/06/07 10:31:28 | Recruitment status Date of IRB Last follow-up date |
|
| 6 | Update | 2020/06/07 10:32:03 | Number of participants that the trial has enrolled |
